| pubmed-article:15911551 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C0042749 | lld:lifeskim |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C0008377 | lld:lifeskim |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C1510802 | lld:lifeskim |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C0384228 | lld:lifeskim |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C0205216 | lld:lifeskim |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C0442967 | lld:lifeskim |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C0939514 | lld:lifeskim |
| pubmed-article:15911551 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
| pubmed-article:15911551 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15911551 | pubmed:dateCreated | 2005-7-22 | lld:pubmed |
| pubmed-article:15911551 | pubmed:abstractText | Treatment failure during highly active antiretroviral therapy (HAART) is ultimately common and associated with the development of resistance mutations. Trizivir (zidovudine/lamivudine/abacavir) and tenofovir disoproxil fumarate may improve adherence and enhance virological suppression in individuals who have failed previous regimens. | lld:pubmed |
| pubmed-article:15911551 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15911551 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15911551 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15911551 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:15911551 | pubmed:issn | 0305-7453 | lld:pubmed |
| pubmed-article:15911551 | pubmed:author | pubmed-author:DaviesElizabe... | lld:pubmed |
| pubmed-article:15911551 | pubmed:author | pubmed-author:MandaliaSundh... | lld:pubmed |
| pubmed-article:15911551 | pubmed:author | pubmed-author:BowerMarkM | lld:pubmed |
| pubmed-article:15911551 | pubmed:author | pubmed-author:GazzardBrianB | lld:pubmed |
| pubmed-article:15911551 | pubmed:author | pubmed-author:NelsonMarkM | lld:pubmed |
| pubmed-article:15911551 | pubmed:author | pubmed-author:StebbingJusti... | lld:pubmed |
| pubmed-article:15911551 | pubmed:author | pubmed-author:MichailidisCh... | lld:pubmed |
| pubmed-article:15911551 | pubmed:author | pubmed-author:LathamVictori... | lld:pubmed |
| pubmed-article:15911551 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15911551 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:15911551 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15911551 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15911551 | pubmed:pagination | 186-9 | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:meshHeading | pubmed-meshheading:15911551... | lld:pubmed |
| pubmed-article:15911551 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15911551 | pubmed:articleTitle | Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol. | lld:pubmed |
| pubmed-article:15911551 | pubmed:affiliation | The St Stephen's Centre, The Chelsea and Westminster Hospital, London, UK. | lld:pubmed |
| pubmed-article:15911551 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15911551 | lld:pubmed |
